Chunghwa Chemical Synthesis & Biotech Co Ltd (CCSB), a subsidiary of China Chemical & Pharmaceutical Co Ltd is a provider of pharmaceutical ingredients. The companys products include laxatives, antifungals, anti-anxiety
Chunghwa Chemical Synthesis & Biotech Co. Ltd., (CCSB), parent company of Pharmaports LLC, founded in 1964, is one of the largest API manufacturer in Taiwan, located in the suburb of Taipei with a manufacturing site of 8.7 acres.
CCSB offers global customers cost-effective APIs with speed from our well trained staff. We shall follow industry best practices in our R&D and manufacturing operations, monitor and respond to all environmental, health, and safety issues, comply with all intellectual property protection requirements, and will not infringe existing any patents. Our goal is not only to build win-win partnerships with our customers, but also to help improve human health by developing effective pharmaceuticals.
CCSB is the first company which got FDA approval to produce synthesis and biotechology API products in the South-East Asia.
Go to 's Website
Chunghwa Chemical Synthesis & Biotech Co Ltd - CPhI …
Pharmaports LLC (PPL) is subsidiary of Chunghwa Chemical Synthesis & Biotech Co., Ltd (CCSB). This location is a sales office as promoting CCSB's products and providing better services to the North American region.
PPL was established in 1999 in New Jersey and then moved to Exton, PA in 2006. Together, CCSB and PPL, has formed an international network providing pharmaceutical ingredients and finished dosages. (API)
Pharmaports LLC will continuously pursue the goal of quality product, quality service and quality people to become a world-wide major supplier of high quality ASPIs with competitive prices.